Georg Klein, Ph.D - Publications

Affiliations: 
Microbiology, Tumor and Cell Biology Karolinska Institute, Stockholm, Sweden 

322 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Madapura HS, Nagy N, Ujvari D, Kallas T, Kröhnke MC, Amu S, Björkholm M, Stenke L, Mandal PK, McMurray JS, Keszei M, Westerberg LS, Cheng H, Xue F, Klein G, et al. Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells. Oncogene. PMID 28368400 DOI: 10.1038/Onc.2017.85  0.372
2015 Mushtaq M, Darekar S, Klein G, Kashuba E. Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells. Plos One. 10: e0136142. PMID 26312753 DOI: 10.1371/Journal.Pone.0136142  0.327
2014 Rasul E, Salamon D, Nagy N, Leveau B, Banati F, Szenthe K, Koroknai A, Minarovits J, Klein G, Klein E. The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia. Plos One. 9: e106008. PMID 25162594 DOI: 10.1371/Journal.Pone.0106008  0.335
2014 Heuts F, Rottenberg ME, Salamon D, Rasul E, Adori M, Klein G, Klein E, Nagy N. T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice. Journal of Virology. 88: 3235-45. PMID 24390326 DOI: 10.1128/Jvi.02885-13  0.329
2014 Hansen KD, Sabunciyan S, Langmead B, Nagy N, Curley R, Klein G, Klein E, Salamon D, Feinberg AP. Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization. Genome Research. 24: 177-84. PMID 24068705 DOI: 10.1101/Gr.157743.113  0.412
2012 Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells. Journal of Immunological Methods. 385: 60-70. PMID 22921685 DOI: 10.1016/J.Jim.2012.08.008  0.362
2012 Darekar S, Georgiou K, Yurchenko M, Yenamandra SP, Chachami G, Simos G, Klein G, Kashuba E. Epstein-barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect Plos One. 7. PMID 22848707 DOI: 10.1371/Journal.Pone.0042072  0.352
2012 Nagy N, Adori M, Rasul A, Heuts F, Salamon D, Ujvári D, Madapura HS, Leveau B, Klein G, Klein E. Soluble factors produced by activated CD4+ T cells modulate EBV latency. Proceedings of the National Academy of Sciences of the United States of America. 109: 1512-7. PMID 22307606 DOI: 10.1073/Pnas.1120587109  0.306
2010 Klein G, Klein E, Kashuba E. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes Biochemical and Biophysical Research Communications. 396: 67-73. PMID 20494113 DOI: 10.1016/J.Bbrc.2010.02.146  0.388
2010 Lacoste S, Wiechec E, Dos Santos Silva AG, Guffei A, Williams G, Lowbeer M, Benedek K, Henriksson M, Klein G, Mai S. Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells Oncogene. 29: 503-515. PMID 19881539 DOI: 10.1038/Onc.2009.359  0.44
2009 Nagy N, Klein G, Klein E. To the genesis of Burkitt lymphoma: Regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes Seminars in Cancer Biology. 19: 407-410. PMID 19874894 DOI: 10.1016/J.Semcancer.2009.10.001  0.329
2009 Nagy N, Matskova L, Kis LL, Hellman U, Klein G, Klein E. The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease Proceedings of the National Academy of Sciences of the United States of America. 106: 11966-11971. PMID 19570996 DOI: 10.1073/Pnas.0905691106  0.31
2009 Yenamandra SP, Lundin A, Arulampalam V, Yurchenko M, Pettersson S, Klein G, Kashuba E. Expression profile of nuclear receptors upon Epstein - Barr virus induced B cell transformation Experimental Oncology. 31: 92-96. PMID 19550398  0.302
2009 Yenamandra SP, Klein G, Kashuba E. Nuclear receptors and their role in Epstein - Barr virus induced B cell transformation Experimental Oncology. 31: 67-73. PMID 19550394  0.341
2007 Stuber G, Mattsson K, Flaberg E, Kati E, Markasz L, Sheldon JA, Klein G, Schulz TF, Szekely L. HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus Molecular Cancer. 6. PMID 17433107 DOI: 10.1186/1476-4598-6-28  0.308
2007 Klein E, Kis LL, Klein G. Epstein-Barr virus infection in humans: From harmless to life endangering virus-lymphocyte interactions Oncogene. 26: 1297-1305. PMID 17322915 DOI: 10.1038/Sj.Onc.1210240  0.458
2006 Ehlin-Henriksson B, Mowafi F, Klein G, Nilsson A. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells Immunology. 117: 379-385. PMID 16476057 DOI: 10.1111/J.1365-2567.2005.02311.X  0.309
2006 Kis LL, Takahara M, Nagy N, Klein G, Klein E. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1 Immunology Letters. 104: 83-88. PMID 16386314 DOI: 10.1016/J.Imlet.2005.11.003  0.331
2005 Bandobashi K, Liu A, Nagy N, Kis LL, Nishikawa J, Björkholm M, Klein G, Klein E. EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells Virus Genes. 30: 323-330. PMID 15830149 DOI: 10.1007/S11262-004-6774-Z  0.325
2005 Kashuba E, Yurchenko M, Szirak K, Stahl J, Klein G, Szekely L. Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein Experimental Cell Research. 303: 47-55. PMID 15572026 DOI: 10.1016/J.Yexcr.2004.08.025  0.314
2005 Kis LL, Nishikawa J, Takahara M, Nagy N, Matskova L, Takada K, Elmberger PG, Ohlsson A, Klein G, Klein E. In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2 International Journal of Cancer. 113: 937-945. PMID 15514968 DOI: 10.1002/Ijc.20654  0.331
2004 Nishikawa J, Kis LL, Liu A, Zhang X, Takahara M, Bandobashi K, Kiss C, Nagy N, Okita K, Klein G, Klein E. Upregulation of LMP1 Expression by Histone Deacetylase Inhibitors in an EBV Carrying NPC Cell Line Virus Genes. 28: 121-128. PMID 14739656 DOI: 10.1023/B:Viru.0000012268.35297.Ff  0.33
2003 Nishikawa J, Kiss C, Imai S, Takada K, Okita K, Klein G, Szekely L. Upregulation of the truncated basic hair keratin 1(hHb1-ΔN) in carcinoma cells by Epstein-Barr virus (EBV) International Journal of Cancer. 107: 597-602. PMID 14520698 DOI: 10.1002/Ijc.11289  0.322
2003 KLEIN G, FORSSBERG A. Studies on the effect of x-rays on the biochemistry and cellular composition of ascites tumors. I. Effect on growth rate, cell volume, nucleic acid and nitrogen content in the Ehrlich ascites tumor. Experimental Cell Research. 6: 211-20. PMID 13141999 DOI: 10.1016/0014-4827(54)90163-9  0.323
2003 Kiss C, Nishikawa J, Takada K, Trivedi P, Klein G, Szekely L. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines. Proceedings of the National Academy of Sciences of the United States of America. 100: 4813-8. PMID 12672960 DOI: 10.1073/Pnas.0730710100  0.319
2003 Ehlin-Henriksson B, Gordon J, Klein G. B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression. Immunology. 108: 427-30. PMID 12667203 DOI: 10.1046/J.1365-2567.2003.01601.X  0.317
2002 Zetterberg H, Jansson A, Rymo L, Chen F, Karlsson A, Klein G, Brodin B. The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site. The Journal of General Virology. 83: 2007-14. PMID 12124465 DOI: 10.1099/0022-1317-83-8-2007  0.37
2002 Pokrovskaja K, Ehlin-Henriksson B, Kiss C, Challa A, Gordon J, Gogolak P, Klein G, Szekely L. CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines International Journal of Cancer. 99: 705-712. PMID 12115504 DOI: 10.1002/Ijc.10417  0.31
2002 Mattsson K, Kiss C, Platt GM, Simpson GR, Kashuba E, Klein G, Schulz TF, Szekely L. Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. The Journal of General Virology. 83: 179-88. PMID 11752715 DOI: 10.1099/0022-1317-83-1-179  0.319
2001 Maeda A, Kiss C, Chen F, Ehlin-Henriksson B, Nagy N, Szekely L, Takada K, Klein E, Klein G. EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain. International Journal of Cancer. 93: 714-9. PMID 11477584 DOI: 10.1002/Ijc.1387  0.315
2001 Classon M, Henriksson M, Sümegi J, Klein G, Hammarskjöld ML. Erratum: Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells (Nature (1987) 330 (272-274)) Nature. 412. DOI: 10.1038/35089110  0.376
2000 Nagy N, Cerboni C, Mattsson K, Maeda A, Gogolák P, Sümegi J, Lányi A, Székely L, Carbone E, Klein G, Klein E. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. International Journal of Cancer. 88: 439-47. PMID 11054674 DOI: 10.1002/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2  0.335
2000 Teramoto N, Maeda A, Kobayashi K, Hayashi K, Oka T, Takahashi K, Takada K, Klein G, Akagi T. Epstein-Barr Virus Infection to Epstein-Barr Virus-Negative Nasopharyngeal Carcinoma Cell Line TW03 Enhances Its Tumorigenicity Laboratory Investigation. 80: 303-312. PMID 10744066 DOI: 10.1038/Labinvest.3780035  0.484
2000 Kiss H, Kedra D, Yang Y, Kost-Alimova M, Kiss C, O'Brien KP, Fransson I, Klein G, Imreh S, Dumanski JP. A novel gene containing LIM domains (LIMD1) is located within the common eliminated region 1 (C3CER1) in 3p21.3. Human Genetics. 105: 552-9. PMID 10647888 DOI: 10.1007/S004399900188  0.305
1999 Szekely L, Kiss C, Mattsson K, Kashuba E, Pokrovskaja K, Juhasz A, Holmvall P, Klein G. Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies. The Journal of General Virology. 80: 2889-2900. PMID 10580050 DOI: 10.1099/0022-1317-80-11-2889  0.302
1999 Kashuba VI, Gizatullin RZ, Protopopov AI, Li J, Vorobieva NV, Fedorova L, Zabarovska VI, Muravenko OV, Kost-Alimova M, Domninsky DA, Kiss C, Allikmets R, Zakharyev VM, Braga EA, Sumegi J, ... ... Klein G, et al. Analysis of NotI linking clones isolated from human chromosome 3 specific libraries. Gene. 239: 259-71. PMID 10548727 DOI: 10.1016/S0378-1119(99)00411-4  0.303
1999 Ehlin-Henriksson B, Zou JZ, Klein G, Ernberg I. Epstein-Barr virus genomes are found predominantly in IgA-positive B cells in the blood of healthy carriers. International Journal of Cancer. 83: 50-4. PMID 10449607 DOI: 10.1002/(Sici)1097-0215(19990924)83:1<50::Aid-Ijc10>3.0.Co;2-1  0.31
1999 Klein G. Immunoglobulin gene associated chromosomal translocations in B-cell derived tumors Current Topics in Microbiology and Immunology. 246: 161-167. PMID 10396052 DOI: 10.1007/978-3-642-60162-0_20  0.398
1999 Pokrovskaja K, Okan I, Kashuba E, L Wbeer M, Klein G, Szekely L. Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis. The Journal of General Virology. 987-995. PMID 10211969 DOI: 10.1099/0022-1317-80-4-987  0.309
1999 Holmgren L, Szeles A, Rajnavölgyi E, Folkman J, Klein G, Ernberg I, Falk KI. Horizontal Transfer of DNA by the Uptake of Apoptotic Bodies Blood. 93: 3956-3963. DOI: 10.1182/blood.V93.11.3956.411k05_3956_3963  0.335
1999 Szeles A, Falk KI, Imreh S, Klein G. Visualization of Alternative Epstein-Barr Virus Expression Programs by Fluorescent In Situ Hybridization at the Cell Level Journal of Virology. 73: 5064-5069. DOI: 10.1128/Jvi.73.6.5064-5069.1999  0.304
1998 HELLSTROM I, HELLSTROM KE, SJOGREN HO, KLEIN G. Superinfection of polyma-induced mouse tumors with polyoma virus in vitro. Experimental Cell Research. 21: 255-9. PMID 13713175 DOI: 10.1016/0014-4827(60)90378-5  0.358
1998 Szekely L, Chen F, Teramoto N, Ehlin-Henriksson B, Pokrovskaja K, Szeles A, Manneborg-Sandlund A, Löwbeer M, Lennette ET, Klein G. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line. The Journal of General Virology. 1445-52. PMID 9634087 DOI: 10.1099/0022-1317-79-6-1445  0.401
1998 Laytragoon-Lewin N, Kashuba V, Mellstedt H, Klein G. bcl-2 rearrangement detected by pulsed-field gel electrophoresis (PFGF) in B-chronic lymphocytic leukemia (CLL) cells. International Journal of Cancer. 76: 909-12. PMID 9626361 DOI: 10.1002/(Sici)1097-0215(19980610)76:6<909::Aid-Ijc23>3.0.Co;2-W  0.319
1998 Kiss C, Li J, Szeles A, Gizatullin RZ, Kashuba VI, Lushnikova T, Protopopov AI, Kelve M, Kiss H, Kholodnyuk ID, Imreh S, Klein G, Zabarovsky ER. Assignment of the ARHA and GPX1 genes to human chromosome bands 3p21.3 by in situ hybridization and with somatic cell hybrids. Cytogenetics and Cell Genetics. 79: 228-30. PMID 9605859 DOI: 10.1159/000134729  0.33
1998 Fisch P, Meuer E, Pende D, Rothenfusser S, Viale O, Kock S, Ferrone S, Fradelizi D, Klein G, Moretta L, Rammensee HG, Boon T, Coulie P, van der Bruggen P. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity. European Journal of Immunology. 27: 3368-79. PMID 9464825 DOI: 10.1002/Eji.1830271236  0.408
1998 Mukherjee S, Trivedi P, Dorfman DM, Klein G, Townsend A. Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells. The Journal of Experimental Medicine. 187: 445-50. PMID 9449725 DOI: 10.1084/Jem.187.3.445  0.385
1998 Kashuba VI, Gizatullin RZ, Protopopov AI, Allikmets R, Korolev S, Li J, Boldog F, Tory K, Zabarovska V, Marcsek Z, Sumegi J, Klein G, Zabarovsky ER, Kisselev L. NotI linking/jumping clones of human chromosome 3: mapping of the TFRC, RAB7 and HAUSP genes to regions rearranged in leukemia and deleted in solid tumors. Febs Letters. 419: 181-5. PMID 9428630 DOI: 10.1016/S0014-5793(97)01449-X  0.34
1997 Trivedi P, Winberg G, Klein G. Differential immunogenicity of Epstein-Barr virus (EBV) encoded growth transformation-associated antigens in a murine model system. European Journal of Cancer (Oxford, England : 1990). 33: 912-7. PMID 9291815 DOI: 10.1016/S0959-8049(96)00514-X  0.457
1997 Pokrovskaja K, Trivedi P, Klein G, Szekely L. Epstein-Barr virus-encoded LMP-1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins. The Journal of General Virology. 2031-40. PMID 9267004 DOI: 10.1099/0022-1317-78-8-2031  0.334
1997 Enblad G, Sandvej K, Lennette E, Sundström C, Klein G, Glimelius B, Pallesen G. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. International Journal of Cancer. 72: 394-7. PMID 9247279 DOI: 10.1002/(Sici)1097-0215(19970729)72:3<394::Aid-Ijc3>3.0.Co;2-K  0.451
1997 Silva S, Wang Y, Babonits M, Imreh S, Wiener F, Klein G. Spontaneous development of plasmacytomas in a selected subline of BALB/cJ mice. European Journal of Cancer (Oxford, England : 1990). 33: 479-85. PMID 9155535 DOI: 10.1016/S0959-8049(97)89025-9  0.304
1997 Laytragoon-Lewin N, Chen F, Avila-Carino J, Klein G, Mellstedt H. Epstein-Barr virus (EBV) gene expression in lymphoid B cells during acute infectious mononucleosis (IM) and clonality of the directly growing cell lines. International Journal of Cancer. 71: 345-9. PMID 9139865 DOI: 10.1002/(Sici)1097-0215(19970502)71:3<345::Aid-Ijc6>3.0.Co;2-Y  0.371
1997 Avila-Cariño J, Lewin N, Tomita Y, Szeles A, Sandlund A, Mosolits S, Mellstedt H, Klein G, Klein E. B-CLL cells with unusual properties. International Journal of Cancer. 70: 1-8. PMID 8985083 DOI: 10.1002/(Sici)1097-0215(19970106)70:1<1::Aid-Ijc1>3.0.Co;2-1  0.366
1997 Gizatullin RZ, Protopopov AI, Zabarovska V, Zakharyev VM, Kashuba VI, Klein G, Zabarovsky ER. Assignment of MOBP, encoding myelin-associated oligodendrocytic basic protein, to human chromosome bands 3p22-->p21.3 using somatic cell hybrids. Cytogenetics and Cell Genetics. 74: 291-2. PMID 8976387 DOI: 10.1159/000134437  0.311
1996 Contreras-Brodin B, Karlsson A, Nilsson T, Rymo L, Klein G. B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter. The Journal of General Virology. 1159-62. PMID 8683201 DOI: 10.1099/0022-1317-77-6-1159  0.321
1996 Allikmets R, Kashuba VI, Huebner K, LaForgia S, Kisselev LL, Klein G, Dean M, Zabarovsky ER. Mapping of 22 Notl linking clones on human chromosome 3 by polymerase chain reaction and somatic cell hybrid panels. Chromosome Research. 4: 33-37. PMID 8653266 DOI: 10.1007/Bf02254942  0.314
1996 Bergerheim US, Söderhäll M, Zabarovsky E, Franzén B, Manneborg-Sandlund A, Li C, Jacobson SH, Auer G, Klein G, Collins VP. Genotypic and phenotypic characterization of two newly established renal cell carcinoma cell lines. Cancer Genetics and Cytogenetics. 86: 95-101. PMID 8603355 DOI: 10.1016/0165-4608(95)00201-4  0.421
1996 Axelson H, Henriksson M, Wang Y, Magnusson KP, Klein G. The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas. European Journal of Cancer (Oxford, England : 1990). 2099-104. PMID 8562172 DOI: 10.1016/0959-8049(95)00449-1  0.309
1996 Lennette ET, Winberg G, Yadav M, Enblad G, Klein G. Antibodies to LMP2A/2B in EBV-carrying malignancies. European Journal of Cancer (Oxford, England : 1990). 1875-8. PMID 8541116 DOI: 10.1016/0959-8049(95)00354-L  0.409
1996 Szekely L, Pokrovskaja K, Jiang WQ, de The H, Ringertz N, Klein G. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. Journal of Virology. 70: 2562-2568. DOI: 10.1128/Jvi.70.4.2562-2568.1996  0.431
1996 Szeles A, Kholodnyuk I, Bajalica S, Lindblom A, Lushnikova T, Kashuba V, Nordenskjöld M, Stanbridge E, Zabarovsky E, Klein G, Imreh S. Localization and ordering of the human 3PK gene and five other human chromosome 3 markers. Attempt to establish the borders of the nonrandomly eliminated putative chromosome 3 tumor suppressor regions in mouse-human microcell hybrid derived SCID tumors Cancer Genetics and Cytogenetics. 91: 186. DOI: 10.1016/S0165-4608(97)82677-5  0.314
1995 Szekely L, Wang Y, Klein G, Wiman KG. RB-reconstituted human retinoblastoma cells form RB-positive intraocular and intracerebral but not subcutaneous tumors in SCID mice. International Journal of Cancer. 61: 683-91. PMID 7768642 DOI: 10.1002/Ijc.2910610516  0.3
1995 Lewin N, Avila-Cariño J, Minarovits J, Lennette E, Brautbar C, Mellstedt H, Klein G, Klein E. Detection of two Epstein-Barr-virus (EBV)-carrying leukemic cell clones in a patient with chronic lymphocytic leukemia (CLL). International Journal of Cancer. 61: 159-64. PMID 7705941 DOI: 10.1002/Ijc.2910610203  0.399
1995 Hu LF, Chen F, Zhen QF, Zhang YW, Luo Y, Zheng X, Winberg G, Ernberg I, Klein G. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. European Journal of Cancer (Oxford, England : 1990). 658-60. PMID 7640034 DOI: 10.1016/0959-8049(94)00468-K  0.322
1995 Laytragoon-Lewin N, Chen F, Avila-Cariño J, Zou JZ, Mellstedt H, Ernberg I, Klein G. Epstein Barr virus (EBV)-carrying cells of a chronic lymphocytic leukemia (CLL) subpopulation express EBNA1 and LMPs but not EBNA2 in vivo. International Journal of Cancer. 63: 486-90. PMID 7591254 DOI: 10.1002/Ijc.2910630404  0.373
1995 Orsini DL, van Gils M, Kooy YM, Struyk L, Klein G, van den Elsen P, Koning F. Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells. European Journal of Immunology. 24: 3199-204. PMID 7528674 DOI: 10.1002/Eji.1830241243  0.308
1995 Chen F, Zou JZ, di Renzo L, Winberg G, Hu LF, Klein E, Klein G, Ernberg I. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. Journal of Virology. 69: 3752-3758. DOI: 10.1128/Jvi.69.6.3752-3758.1995  0.462
1994 Trivedi P, Hu LF, Chen F, Christensson B, Masucci MG, Klein G, Winberg G. Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. European Journal of Cancer (Oxford, England : 1990). 84-8. PMID 8142171 DOI: 10.1016/S0959-8049(05)80024-3  0.452
1994 Minarovits J, Hu LF, Imai S, Harabuchi Y, Kataura A, Minarovits-Kormuta S, Osato T, Klein G. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. The Journal of General Virology. 77-84. PMID 8113742 DOI: 10.1099/0022-1317-75-1-77  0.41
1994 Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells Cell. 77: 791-793. PMID 8004668 DOI: 10.1016/0092-8674(94)90125-2  0.311
1994 Imreh S, Wang Y, Panda CK, Babonits M, Axelson H, Silva S, Szeles A, Wiener F, Klein G. Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophage-monocytic tumour line. European Journal of Cancer (Oxford, England : 1990). 994-1002. PMID 7946599 DOI: 10.1016/0959-8049(94)90131-7  0.32
1994 Imreh S, Kholodnyuk I, Stanbridge E, Zabarovsky E, Klein G. Nonrandom loss of human chromosome 3 fragments in scid tumors of mouse/human microcell hybrids. A potential method for tumor suppressor gene isolation? Cancer Genetics and Cytogenetics. 77: 153. DOI: 10.1016/0165-4608(94)90249-6  0.307
1993 Trivedi P, Cuomo L, de Campos-Lima PO, Imreh MP, Kvarnung K, Klein G, Masucci MG. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5. The Journal of General Virology. 1393-8. PMID 8393080 DOI: 10.1099/0022-1317-74-7-1393  0.362
1993 Fåhraeus R, Jansson A, Sjöblom A, Nilsson T, Klein G, Rymo L. Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences. Virology. 195: 71-80. PMID 8391188 DOI: 10.1006/Viro.1993.1347  0.317
1993 Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proceedings of the National Academy of Sciences of the United States of America. 90: 5455-9. PMID 8390666 DOI: 10.1073/Pnas.90.12.5455  0.403
1993 Cuomo L, Zhang QJ, Lombardi L, Torsteinsdottir S, Klein G, Dalla-Favera R, Masucci MG. Over-expression of c-myc increases the sensitivity of Epstein-Barr virus immortalized lymphoblastoid cells to non-MHC-restricted cytotoxicity International Journal of Cancer. 53: 1008-1012. PMID 8386135 DOI: 10.1002/Ijc.2910530625  0.334
1993 de Campos-Lima PO, Torsteinsdóttir S, Cuomo L, Klein G, Sulitzeanu D, Masucci MG. Antigen processing and presentation by EBV-carrying cell lines: cell-phenotype dependence and influence of the EBV-encoded LMP1. International Journal of Cancer. 53: 856-62. PMID 8383631 DOI: 10.1002/Ijc.2910530525  0.32
1993 Cuomo L, Trivedi P, de Campos-Lima PO, Zhang QJ, Ragnar E, Klein G, Masucci MG. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines. Molecular Immunology. 30: 441-50. PMID 7681932 DOI: 10.1016/0161-5890(93)90112-O  0.314
1993 Silva S, Wang Y, Babonits M, Axelson H, Wiener F, Klein G. An exceptional mouse plasmacytoma with a new kappa/N-myc [T(6; 12) (C1; B)] translocation expresses N-myc but not c-myc. Current Topics in Microbiology and Immunology. 182: 251-9. PMID 1490362 DOI: 10.1007/978-3-642-77633-5_31  0.354
1992 Wennborg AD, Altiok E, Moore JP, Ernberg I, Klein G. Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid lines. European Journal of Cancer (Oxford, England : 1990). 27: 1643-5. PMID 1782076 DOI: 10.1016/0277-5379(91)90436-H  0.307
1992 Contreras-Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. The Journal of General Virology. 3025-33. PMID 1662694 DOI: 10.1099/0022-1317-72-12-3025  0.378
1992 Jiang WQ, Szekely L, Wendel-Hansen V, Ringertz N, Klein G, Rosén A. Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Experimental Cell Research. 197: 314-8. PMID 1659990 DOI: 10.1016/0014-4827(91)90438-Z  0.38
1992 Altiok E, Minarovits J, Hu LF, Contreras-Brodin B, Klein G, Ernberg I. Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6. Proceedings of the National Academy of Sciences of the United States of America. 89: 905-9. PMID 1371012 DOI: 10.1073/Pnas.89.3.905  0.462
1992 Cuomo L, Ramquist T, Trivedi P, Wang F, Klein G, Masucci MG. Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line. International Journal of Cancer. 51: 949-55. PMID 1322379 DOI: 10.1002/Ijc.2910510619  0.369
1992 Minarovits J, Hu LF, Marcsek Z, Minarovits-Kormuta S, Klein G, Ernberg I. RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types. The Journal of General Virology. 1687-92. PMID 1321209 DOI: 10.1099/0022-1317-73-7-1687  0.406
1991 Lewin N, Aman P, Akerlund B, Gustavsson E, Carenfelt C, Lejdeborn L, Klein G, Klein E. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation. Immunology Letters. 26: 59-65. PMID 2177451 DOI: 10.1016/0165-2478(90)90176-Q  0.369
1991 Falk K, Ernberg I, Sakthivel R, Davis J, Christensson B, Luka J, Okano M, Grierson HL, Klein G, Purtilo DT. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis. International Journal of Cancer. 46: 976-84. PMID 2174416 DOI: 10.1002/Ijc.2910460605  0.367
1991 Steinitz M, Rosén A, Klein G. An improved dot immunobinding assay for screening hybridoma supernatants. Non-purified antigen immobilized on nitrocellulose paper discs. Journal of Immunological Methods. 136: 119-123. PMID 1995705 DOI: 10.1016/0022-1759(91)90257-G  0.301
1991 Lewin N, Minarovits J, Weber G, Ehlin-Henriksson B, Wen T, Mellstedt H, Klein G, Klein E. Clonality and methylation status of the Epstein-Barr virus (EBV) genomes in in vivo-infected EBV-carrying chronic lymphocytic leukemia (CLL) cell lines. International Journal of Cancer. 48: 62-6. PMID 1850384 DOI: 10.1002/Ijc.2910480112  0.393
1991 Gratama JW, Zutter MM, Minarovits J, Oosterveer MA, Thomas ED, Klein G, Ernberg I. Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. International Journal of Cancer. Journal International Du Cancer. 47: 188-92. PMID 1846349 DOI: 10.1002/Ijc.2910470205  0.308
1991 Trivedi P, Masucci MG, Winberg G, Klein G. The epstein-Barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells. International Journal of Cancer. 48: 794-800. PMID 1649140 DOI: 10.1002/Ijc.2910480527  0.324
1991 Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region. Journal of Virology. 65: 1558-1567. DOI: 10.1128/Jvi.65.3.1558-1567.1991  0.383
1990 Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. The Journal of General Virology. 2989-3002. PMID 2479717 DOI: 10.1099/0022-1317-70-11-2989  0.413
1990 Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. European Journal of Immunology. 20: 2293-9. PMID 2173662 DOI: 10.1002/Eji.1830201019  0.377
1990 Pérez M, Algarra I, Ljunggren HG, Caballero A, Mialdea MJ, Gaforio JJ, Klein G, Kärre K, Garrido F. A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma. International Journal of Cancer. 46: 258-61. PMID 2116997 DOI: 10.1002/Ijc.2910460219  0.316
1990 Bejarano MT, Masucci MG, Morgan A, Morein B, Klein G, Klein E. Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation. Journal of Virology. 64: 1398-1401. DOI: 10.1128/Jvi.64.3.1398-1401.1990  0.458
1990 Contreras-Salazar B, Ehlin-Henriksson B, Klein G, Masucci MG. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection. Journal of Virology. 64: 5441-5447. DOI: 10.1128/Jvi.64.11.5441-5447.1990  0.452
1990 Gratama JW, Oosterveer MA, Klein G, Ernberg I. EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families. Journal of Virology. 64: 4703-4708. DOI: 10.1128/Jvi.64.10.4703-4708.1990  0.325
1989 Henriksson M, Classon M, Hammarskjöld ML, Klein G, Sumegi J. The replication activity of SV40 DNA correlates with the level of c-myc expression in human tumor cell lines. Current Topics in Microbiology and Immunology. 141: 202-7. PMID 2850893 DOI: 10.1007/978-3-642-74006-0_27  0.356
1989 Torsteinsdóttir S, Andersson ML, Avila-Cariño J, Ehlin-Henriksson B, Masucci MG, Klein G, Klein E. Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an IgH/myc translocation-carrying BL line. International Journal of Cancer. 43: 273-8. PMID 2645221 DOI: 10.1002/Ijc.2910430219  0.318
1989 Kurakata S, Ramos OF, Klein G, Klein E. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms. Cellular Immunology. 123: 134-47. PMID 2550147 DOI: 10.1016/0008-8749(89)90274-8  0.384
1989 Altiok E, Klein G, Zech L, Uno M, Henriksson BE, Battat S, Ono Y, Ernberg I. Epstein-Barr virus-transformed pro-B cells are prone to illegitimate recombination between the switch region of the μ chain gene and other chromosomes Proceedings of the National Academy of Sciences of the United States of America. 86: 6333-6337. PMID 2548209 DOI: 10.1073/Pnas.86.16.6333  0.386
1989 Masucci G, Mellstedt H, Henle G, Henle W, Rymo L, Masucci MG, Ernberg I, Klein G. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients. International Journal of Cancer. Journal International Du Cancer. 43: 1017-21. PMID 2543639 DOI: 10.1002/Ijc.2910430610  0.348
1989 Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I, Klein G. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. Journal of Virology. 63: 3135-3141. DOI: 10.1128/Jvi.63.7.3135-3141.1989  0.499
1989 Contreras-Salazar B, Klein G, Masucci MG. Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids. Journal of Virology. 63: 2768-2772. DOI: 10.1128/Jvi.63.6.2768-2772.1989  0.497
1988 Ljunggren HG, Yamasaki T, Collins P, Klein G, Kärre K. Selective acceptance of MHC class I-deficient tumor grafts in the brain. The Journal of Experimental Medicine. 167: 730-5. PMID 3346626 DOI: 10.1084/Jem.167.2.730  0.336
1988 Höglund P, Ljunggren HG, Ohlén C, Ahrlund-Richter L, Scangos G, Bieberich C, Jay G, Klein G, Kärre K. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice. The Journal of Experimental Medicine. 168: 1469-74. PMID 3171481 DOI: 10.1084/Jem.168.4.1469  0.326
1988 Klein G. Oncogenes and tumor suppressor genes Acta Oncologica. 27: 427-437. PMID 2849463 DOI: 10.3109/02841868809093569  0.344
1988 Gratama JW, Oosterveer MA, Zwaan FE, Lepoutre J, Klein G, Ernberg I. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proceedings of the National Academy of Sciences of the United States of America. 85: 8693-6. PMID 2847171 DOI: 10.1073/Pnas.85.22.8693  0.386
1988 Patel GV, Masucci MG, Winberg G, Klein G. Expression of the Epstein-Barr virus encoded EBNA-1 gene in stably transfected human and murine cell lines. International Journal of Cancer. 42: 592-8. PMID 2844682 DOI: 10.1002/Ijc.2910420421  0.357
1988 Bejarano MT, Masucci MG, Klein G, Klein E. T-cell-mediated inhibition of EBV-induced B-cell transformation: recognition of virus particles. International Journal of Cancer. 42: 359-64. PMID 2843474 DOI: 10.1002/Ijc.2910420309  0.325
1988 Hatzubai A, Lerner RA, Klein G, Sulitzeanu D. Proteins in normal and malignant cells, cross-reacting with the latent membrane protein encoded by Epstein-Barr virus. European Journal of Immunology. 18: 1283-8. PMID 2843380 DOI: 10.1002/Eji.1830180820  0.315
1988 Lewin N, Aman P, Mellstedt H, Zech L, Klein G. Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines International Journal of Cancer. 41: 892-895. PMID 2836321 DOI: 10.1002/Ijc.2910410621  0.384
1988 Ricksten A, Kallin B, Alexander H, Dillner J, Fåhraeus R, Klein G, Lerner R, Rymo L. BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins. Proceedings of the National Academy of Sciences of the United States of America. 85: 995-9. PMID 2829223 DOI: 10.1073/Pnas.85.4.995  0.465
1987 Wendel-Hansen V, Rosén A, Klein G. EBV-transformed lymphoblastoid cell lines down-regulate EBNA in parallel with secretory differentiation. International Journal of Cancer. 39: 404-8. PMID 3546163 DOI: 10.1002/Ijc.2910390322  0.367
1987 Welinder C, Larsson NG, Szigeti R, Ehlin-Henriksson B, Henle G, Henle W, Klein G, Ricksten A, Rymo L, Sulitzeanu D. Stable transfection of a human lymphoma line by sub-genomic fragments of Epstein-Barr virus DNA to measure humoral and cellular immunity to the corresponding proteins. International Journal of Cancer. Journal International Du Cancer. 40: 389-95. PMID 3040603 DOI: 10.1002/Ijc.2910400318  0.407
1987 Hatzubai A, Anafi M, Masucci MG, Dillner J, Lerner RA, Klein G, Sulitzeanu D. Down-regulation of the EBV-encoded membrane protein (LMP) in Burkitt lymphomas. International Journal of Cancer. 40: 358-64. PMID 3040601 DOI: 10.1002/Ijc.2910400313  0.437
1987 Bejarano MT, Thorsteinsdottir S, Andersson JP, Andersson UG, Masucci MG, Szigeti R, Klein E, Klein G. Defective cell-mediated response to EBV-transformed B cells in a healthy individual with regular EBV antibody titers. International Journal of Cancer. 40: 149-56. PMID 3038755 DOI: 10.1002/Ijc.2910400204  0.335
1987 Masucci G, Mellstedt H, Masucci MG, Ernberg I, Szigeti R, Henle G, Henle W, Klein G. Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphoma. European Journal of Cancer & Clinical Oncology. 23: 379-86. PMID 3038561 DOI: 10.1016/0277-5379(87)90373-7  0.34
1987 Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proceedings of the National Academy of Sciences of the United States of America. 84: 4567-71. PMID 3037521 DOI: 10.1073/Pnas.84.13.4567  0.428
1987 Lewin N, Aman P, Masucci MG, Klein E, Klein G, Oberg B, Strander H, Henle W, Henle G. Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. International Journal of Cancer. Journal International Du Cancer. 39: 472-6. PMID 3030940 DOI: 10.1002/Ijc.2910390411  0.347
1987 Otsu M, Katamine S, Uno M, Yamaki M, Ono Y, Klein G, Sasaki MS, Yaoita Y, Honjo T. Molecular characterization of novel reciprocal translocation t(6;14) in an Epstein-Barr virus-transformed B cell precursor. Molecular and Cellular Biology. 7: 708-17. PMID 3029565 DOI: 10.1128/Mcb.7.2.708  0.33
1987 Klein E, Torsteinsdottir S, Masucci MG, Klein G. Different sensitivity of B cell lines derived from Burkitt lymphoma (BL) and normal cells (LCL) to cytotoxic T cell clones generated by autologous and allogeneic stimulation. Journal of Immunogenetics. 13: 269-74. PMID 3029233 DOI: 10.1111/J.1744-313X.1986.Tb01111.X  0.426
1987 Ehlin-Henriksson B, Manneborg-Sandlund A, Klein G. Expression of B-cell-specific markers in different Burkitt lymphoma subgroups. International Journal of Cancer. 39: 211-8. PMID 3026973 DOI: 10.1002/Ijc.2910390215  0.301
1987 Avila-Cariño J, Torsteinsdottir S, Ehlin-Henriksson B, Lenoir G, Klein G, Klein E, Masucci MG. Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures. International Journal of Cancer. 40: 691-7. PMID 2824386 DOI: 10.1002/Ijc.2910400521  0.469
1987 Finke J, Rowe M, Kallin B, Ernberg I, Rosén A, Dillner J, Klein G. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. Journal of Virology. 61: 3870-3878. DOI: 10.1128/jvi.61.12.3870-3878.1987  0.329
1986 Kallin B, Dillner J, Ernberg I, Ehlin-Henriksson B, Rosén A, Henle W, Henle G, Klein G. Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proceedings of the National Academy of Sciences of the United States of America. 83: 1499-503. PMID 3485288 DOI: 10.1073/Pnas.83.5.1499  0.479
1986 Szigeti R, Rabin H, Timar L, Klein G. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses. Intervirology. 26: 121-8. PMID 3034820 DOI: 10.1159/000149691  0.374
1986 Aman P, Lewin N, Nordström M, Klein G. EBV-activation of human B-lymphocytes. Current Topics in Microbiology and Immunology. 132: 266-71. PMID 3024919 DOI: 10.1007/978-3-642-71562-4_40  0.502
1986 Szigeti R, Timar L, Weiland O, Henle W, Henle G, Hennessy K, Kieff E, Sulitzeanu D, Dillner J, Klein G. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells. Clinical Immunology and Immunopathology. 41: 342-50. PMID 3022972 DOI: 10.1016/0090-1229(86)90005-X  0.361
1986 Ernberg I, Kallin B, Dillner J, Falk K, Ehlin-Henriksson B, Hammarskjöld ML, Klein G. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen. International Journal of Cancer. 38: 729-37. PMID 3021635 DOI: 10.1002/Ijc.2910380517  0.372
1986 Ernberg I, Björkholm M, Zech L, Sandstedt B, Szigeti R, Andersson J, Henle W, Klein G. An EBV genome carrying pre-B cell leukemia in a homosexual man with characteristic karyotype and impaired EBV-specific immunity. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 4: 1481-8. PMID 3020182 DOI: 10.1200/Jco.1986.4.10.1481  0.383
1986 Hammarskjöld ML, Wang SC, Klein G. High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector. Gene. 43: 41-50. PMID 3019836 DOI: 10.1016/0378-1119(86)90006-5  0.366
1986 Torsteinsdottir S, Masucci MG, Brautbar C, Lenoir G, Klein G, Klein E. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones. Cellular Immunology. 98: 453-66. PMID 3019570 DOI: 10.1016/0008-8749(86)90304-7  0.352
1986 Dillner J, Kallin B, Alexander H, Ernberg I, Uno M, Ono Y, Klein G, Lerner RA. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines. Proceedings of the National Academy of Sciences of the United States of America. 83: 6641-5. PMID 3018741 DOI: 10.1073/Pnas.83.17.6641  0.49
1986 Torsteinsdottir S, Masucci MG, Ehlin-Henriksson B, Brautbar C, Ben Bassat H, Klein G, Klein E. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 83: 5620-4. PMID 3016710 DOI: 10.1073/Pnas.83.15.5620  0.461
1986 Hu CP, Aman P, Masucci MG, Klein E, Klein G. B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV). European Journal of Immunology. 16: 841-5. PMID 3013647 DOI: 10.1002/Eji.1830160720  0.361
1986 Sumegi J, Sejersen T, Björklund H, Klein G, Ringertz NR. Differential expression of N-myc, c-myc and c-src proto-oncogenes during the course of induced differentiation of murine embryonal carcinoma cells. Current Topics in Microbiology and Immunology. 132: 297-304. PMID 2431836 DOI: 10.1007/978-3-642-71562-4_44  0.302
1985 Gazitt Y, Ehlin-Henriksson B, Lerner A, Klein G. Subgroup analysis of BL-cell lines with polyclonal BL-specific antibodies. International Journal of Cancer. 34: 839-43. PMID 6439652 DOI: 10.1002/Ijc.2910340615  0.322
1985 Taniguchi K, Kärre K, Klein G. Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell. International Journal of Cancer. 36: 503-10. PMID 4044058 DOI: 10.1002/Ijc.2910360415  0.343
1985 Fahrlander PD, Sumegi J, Yang J, Wiener F, Marcu KB, Klein G. Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma. Proceedings of the National Academy of Sciences of the United States of America. 82: 3746-3750. PMID 2987943 DOI: 10.1073/Pnas.82.11.3746  0.313
1985 Rymo L, Klein G, Ricksten A. Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome. Proceedings of the National Academy of Sciences of the United States of America. 82: 3435-9. PMID 2987926 DOI: 10.1073/Pnas.82.10.3435  0.361
1985 Szigeti R, Masucci MG, Masucci G, Aman P, Klein G, Klein E. Leukocyte migration inhibitory factor production by activated lymphocytes representing immunological memory or virus-receptor interaction: response of T cell subsets to Epstein-Barr virus nuclear antigen, response of B cells to UV inactivated Epstein-Barr virus. Immunology Letters. 9: 267-73. PMID 2987111 DOI: 10.1016/0165-2478(85)90006-9  0.336
1985 Kallin B, Sternås L, Saemundssen AK, Luka J, Jörnvall H, Eriksson B, Tao PZ, Nilsson MT, Klein G. Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells. Journal of Virology. 54: 561-8. PMID 2985818 DOI: 10.1128/Jvi.54.2.561-568.1985  0.324
1985 Dillner J, Kallin B, Ehlin-Henriksson B, Timar L, Klein G. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA. International Journal of Cancer. 35: 359-66. PMID 2982749 DOI: 10.1002/Ijc.2910350312  0.377
1985 SÜMEGI J, HEDBERG T, BJÖRKHOLM M, GODAL T, MELLSTEDT H, NILSSON M, PERLMAN C, KLEIN G. AMPLIFICATION OF THE C-MYC ONCOGENE IN HUMAN PLASMA-CELL LEUKEMIA International Journal of Cancer. 36: 367-371. DOI: 10.1002/Ijc.1985.36.3.367  0.355
1984 Wiener F, Babonits M, Bregula U, Klein G, Léonard A, Wax JS, Potter M. High resolution banding analysis of the involvement of strain BALB/c- and AKR-derived chromosomes No. 15 in plasmacytoma-specific translocations. The Journal of Experimental Medicine. 159: 276-91. PMID 6607313 DOI: 10.1084/Jem.159.1.276  0.318
1984 Szigeti R, Sulitzeanu D, Henle G, Henle W, Klein G. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. Proceedings of the National Academy of Sciences of the United States of America. 81: 4178-82. PMID 6330746 DOI: 10.1073/Pnas.81.13.4178  0.362
1984 Torsteinsdottir S, Masucci MG, Lenoir G, Klein G, Klein E. Natural killer cell sensitivity of human lymphoid lines of B-cell origin does not correlate with tumorigenicity or with the expression of certain differentiation markers. Cellular Immunology. 86: 278-86. PMID 6329520 DOI: 10.1016/0008-8749(84)90382-4  0.467
1984 Masucci G, Szigeti R, Stevens D, Masucci MG, Klein E, Petersen J, Bendtzen K, Klein G. Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activators. Cellular Immunology. 85: 511-8. PMID 6325026 DOI: 10.1016/0008-8749(84)90263-6  0.394
1984 Wells A, Koide N, Eggertsen G, Lundwall A, Godal T, Steen HB, Klein G. Epstein-Barr virus binding to virus-carrying cell lines is enhanced in the presence of C3 and C3d. The Journal of General Virology. 507-13. PMID 6321638 DOI: 10.1099/0022-1317-65-3-507  0.303
1984 Aman P, Ehlin-Henriksson B, Klein G. Epstein-Barr virus susceptibility of normal human B lymphocyte populations. The Journal of Experimental Medicine. 159: 208-20. PMID 6319530 DOI: 10.1084/Jem.159.1.208  0.432
1984 Merino F, Grönberg A, Klein G. T-cell-dependent hybrid resistance against a natural killer-resistant Moloney virus-induced lymphoma (YWA): in vitro generation of cytotoxic lymphocytes. Cellular Immunology. 83: 313-20. PMID 6229343 DOI: 10.1016/0008-8749(84)90310-1  0.319
1984 Ohno S, Migita S, Wiener F, Babonits M, Klein G, Mushinski JF, Potter M. Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus. The Journal of Experimental Medicine. 159: 1762-77. PMID 6202819 DOI: 10.1084/Jem.159.6.1762  0.372
1983 Jønsson V, Wells A, Klein G. Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids. Cellular Immunology. 72: 263-76. PMID 6983911 DOI: 10.1016/0008-8749(82)90474-9  0.386
1983 Lindemalm C, Biberfeld P, Björkholm M, Henle G, Henle W, Holm G, Johansson B, Klein G, Mellstedt H. Epstein-Barr virus-associated antibody pattern in untreated non-Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions. International Journal of Cancer. Journal International Du Cancer. 32: 675-82. PMID 6317577 DOI: 10.1002/Ijc.2910320605  0.37
1983 Klein G, Manneborg-Sandlund A, Ehlin-Henriksson B, Godal T, Wiels J, Tursz T. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias. International Journal of Cancer. 31: 535-42. PMID 6303966 DOI: 10.1002/Ijc.2910310503  0.348
1983 Patarroyo M, Klein E, Klein G. Lymphocyte-mediated lysis of autologous and allogeneic B-cell lines in man. Immunology Letters. 6: 101-5. PMID 6303952 DOI: 10.1016/0165-2478(83)90089-5  0.305
1983 Johnson DR, Wolfe LG, Levan G, Klein G, Ernberg I, Aman P. Epstein-Barr virus (EBV)-induced lymphoproliferative disease in cotton-topped marmosets. International Journal of Cancer. 31: 91-7. PMID 6299974 DOI: 10.1002/Ijc.2910310115  0.309
1983 Eliasson L, Kallin B, Patarroyo M, Klein G, Fujiki H, Sugimura T. Activation of the EBV-cycle and aggregation of human blood lymphocytes by the tumor promoters teleocidin, lyngbyatoxin A, aplysiatoxin and debromoaplysiatoxin. International Journal of Cancer. 31: 7-11. PMID 6299973 DOI: 10.1002/Ijc.2910310103  0.375
1983 Kallin B, Klein G. Epstein-Barr virus carried by Raji cells: a mutant in early functions? Intervirology. 19: 47-51. PMID 6298144 DOI: 10.1159/000149336  0.31
1983 Ernberg I, Klein G, Giovanella BC, Stehlin J, McCormick KJ, Andersson-Anvret M, Aman P, Killander D. Relationship between the amounts of EBV-DNA and EBNA per cell, clonability and tumorigenicity in two ebv-negative lymphoma lines and their EBV-converted sublines. International Journal of Cancer. 31: 163-9. PMID 6298125 DOI: 10.1002/Ijc.2910310206  0.419
1983 Anisimová E, Saemundsen AK, Roubal J, Vonka V, Klein G. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. The Journal of General Virology. 163-71. PMID 6292341 DOI: 10.1099/0022-1317-58-1-163  0.367
1982 Gazitt Y, Klein G, Sulitzeanu D. Reactivity with patient antibodies of partially purified gp40 antigen from immune complexes in Burkitt's lymphoma and nasopharyngeal carcinoma. International Journal of Cancer. 29: 645-51. PMID 7107067 DOI: 10.1002/Ijc.2910290608  0.327
1982 Spira G, Koide N, Aman P, Ber R, Klein G. Truncated mu chain in a Burkitt lymphoma line (P3HR-1) and its fate in various hemapoietic somatic cell hybrids. Immunobiology. 162: 199-209. PMID 6811418 DOI: 10.1016/S0171-2985(11)80031-8  0.363
1982 Szigeti R, Masucci MG, Henle W, Henle G, Purtilo D, Klein G. Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies. Clinical Immunology and Immunopathology. 22: 128-38. PMID 6288294 DOI: 10.1016/0090-1229(82)90029-0  0.414
1982 Tsukuda K, Tsukuda Y, Klein G. Suppressor T cells activated by autologous B-cell derived lines inhibit blastogenic responses by peripheral lymphocytes to mitogens or autologous lymphoblastoid cell lines. Cellular Immunology. 69: 291-304. PMID 6286150 DOI: 10.1016/0008-8749(82)90074-0  0.305
1982 Shapiro IM, Volsky DJ, Saemundsen AK, Anisimova E, Klein G. Infection of the human T-cell-derived leukemia line Molt-4 by Epstein-Barr virus (EBV): induction of EBV-determined antigens and virus reproduction. Virology. 120: 171-81. PMID 6285596 DOI: 10.1016/0042-6822(82)90015-0  0.607
1982 Koide N, Wells A, Klein G, Ernberg I. Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines. Intervirology. 16: 142-8. PMID 6277822 DOI: 10.1159/000149261  0.319
1982 Tsukuda K, Volsky DJ, Shapiro IM, Klein G. Epstein-Barr virus (EBV) receptor implantation onto human B lymphocytes changes immunoglobulin secretion patterns induced by EBV infection. European Journal of Immunology. 12: 87-90. PMID 6277643 DOI: 10.1002/Eji.1830120116  0.577
1982 McCormick KH, Giovanella BC, Klein G, Nilsson K, Stehlin JS. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice. International Journal of Cancer. 28: 455-8. PMID 6273332 DOI: 10.1002/Ijc.2910280410  0.334
1982 Patarroyo M, Klein E, Klein G. The increased natural killer sensitivity of Epstein-Barr virus (EBV)-superinfected Raji cells is not due to the recognition of serologically determined EBV antigens by the effectors. Cellular Immunology. 67: 152-9. PMID 6176334 DOI: 10.1016/0008-8749(82)90207-6  0.337
1982 Ben-Sasson SA, Klein G. Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines. International Journal of Cancer. 28: 131-5. PMID 6172387 DOI: 10.1002/Ijc.2910280204  0.322
1982 Wells A, Koide N, Klein G. Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells. Journal of Virology. 41: 286-297. DOI: 10.1128/Jvi.41.1.286-297.1982  0.363
1981 Gazitt Y, Gilead Z, Klein G, Sulitzeanu D. A technique for the identification of glycoprotein antigens in immune complexes and its application to the detection of a common glycoprotein in sera of patients with Burkitt's lymphoma and nasopharyngeal carcinoma. Journal of Immunological Methods. 43: 49-57. PMID 7264319 DOI: 10.1016/0022-1759(81)90035-1  0.313
1981 Spira J, Asjö B, Cochran A, Shen FW, Wiener F, Klein G. Chromosomal, histopathological and cell surface marker studies on Moloney virus induced lymphomas. Leukemia Research. 5: 113-21. PMID 7017292 DOI: 10.1016/0145-2126(81)90069-2  0.347
1981 Volsky DJ, Ahrlund-Richter L, Dalianis T, Klein G. Implantation of mouse histocompatibility antigens into membranes of cultured tumor cells. European Journal of Immunology. 11: 341-4. PMID 6972874 DOI: 10.1002/Eji.1830110415  0.549
1981 Wiener F, Spira J, Babonits M, Haran-Ghera N, Klein G. Non-random duplication of chromosome 15 in murine T-cell leukemias: further studies on translocation heterozygotes. International Journal of Cancer. 26: 661-8. PMID 6972359 DOI: 10.1002/Ijc.2910260519  0.317
1981 Povey S, Jeremiah S, Arthur E, Ber R, Fialkow PJ, Gardiner E, Goodfellow PN, Karande A, Klein G, Quintero M, Steel CM, Zeuthen J. Deficiency of malic enzyme: a possible marker for malignancy in lymphoid cells. Annals of Human Genetics. 45: 237-52. PMID 6946723 DOI: 10.1111/J.1469-1809.1981.Tb00335.X  0.387
1981 Johnson DR, Ohno S, Kaschka-Dierich C, Fleckenstein B, Klein G. Relationship between Herpesvirus ateles-associated nuclear antigen (HATNA) and the number of virus genome equivalents in HVA-carrying lymphoid lines. The Journal of General Virology. 52: 221-6. PMID 6793691 DOI: 10.1099/0022-1317-52-2-221  0.328
1981 Wiener F, Babonits M, Spira J, Bregula U, Klein G, Merwin RM, Asofsky R, Lynes M, Haughton G. Chromosome 15 trisomy in spontaneous and carcinogen-induced murine lymphomas of B-cell origin. International Journal of Cancer. 27: 51-8. PMID 6788720 DOI: 10.1002/Ijc.2910270109  0.4
1981 Tsukuda K, Tsukuda Y, Klein G. Suppressor T cells activated by lymphoblastoid cell lines inhibit pokeweed mitogen-induced immunoglobulin synthesis. Cellular Immunology. 60: 191-202. PMID 6453655 DOI: 10.1016/0008-8749(81)90259-8  0.329
1981 Szigeti R, Klein G, Luka J, Volsky DJ. [Leukocyte migration inhibition evoked by Epstein Barr virus antigen. I. Immune response in healthy donors]. Orvosi Hetilap. 122: 2327-31. PMID 6273776  0.515
1981 Rymo L, Lindahl T, Povey S, Klein G. Analysis of restriction endonuclease fragments of intracellular Epstein-Barr virus DNA and isoenzymes indicate a common origin of the Raji, NC-37, and F-265 human lymphoid cell lines. Virology. 115: 115-24. PMID 6270894 DOI: 10.1016/0042-6822(81)90093-3  0.303
1981 Koide N, Wells A, Volsky DJ, Shapiro IM, Klein G. The detection of Epstein-Barr virus receptors utilizing radiolabelled virus. The Journal of General Virology. 54: 191-5. PMID 6270245 DOI: 10.1099/0022-1317-54-1-191  0.588
1981 Wells A, Koide N, Klein G. Difference in viral binding between two Epstein-Barr virus substrains to a spectrum of receptor-positive target cells. International Journal of Cancer. 27: 303-9. PMID 6270014 DOI: 10.1002/Ijc.2910270308  0.336
1981 Patarroyo M, Blazar B, Pearson G, Klein E, Klein G. Induction of the EBV cycle in B-lymphocyte-derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV-related antigen(s) detected by the ADCC reaction. International Journal of Cancer. 26: 365-71. PMID 6270007 DOI: 10.1002/Ijc.2910260317  0.316
1981 Volsky DJ, Klein G, Volsky B, Shapiro IM. Production of infectious Epstein--Barr virus in mouse lymphocytes. Nature. 293: 399-401. PMID 6268991 DOI: 10.1038/293399A0  0.59
1981 Roubal J, Klein G. Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells. Intervirology. 15: 43-8. PMID 6268568 DOI: 10.1159/000149213  0.317
1981 Patarroyo M, Biberfeld P, Klein E, Klein G. 12-O- tetradecanoylphorbol- 13 acetate (TPA) treatment elevates the natural killer (NK) sensitivity of certain human lymphoid lines. Cellular Immunology. 63: 237-48. PMID 6268309 DOI: 10.1016/0008-8749(81)90003-4  0.329
1981 Johnson DR, Levan G, Klein G, Nigida SM, Wolfe LG. Chromosomes and cell surface markers of marmoset lymphocytes and Epstein-Barr virus-transformed marmoset cell lines. Cancer Genetics and Cytogenetics. 3: 101-8. PMID 6268289 DOI: 10.1016/0165-4608(81)90064-9  0.354
1981 Jønsson V, Klein G. Fc and C3 receptor patterns on two EBV- negative Burkitt lymphoma lines during acute exposure to EBV (P3HR-1 substrain). European Journal of Cancer. 17: 161-5. PMID 6266834 DOI: 10.1016/0014-2964(81)90031-1  0.363
1981 Shapiro IM, Klein G, Volsky DJ. Epstein-Barr virus co-reconstituted with Sendai virus envelopes infects Epstein-Barr virus-receptor negative cells. Biochimica Et Biophysica Acta. 676: 19-24. PMID 6266500 DOI: 10.1016/0304-4165(81)90004-0  0.607
1981 Staczek J, Steplewski Z, Weinmann R, Klein G, Koprowski H. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids. Journal of Cellular Physiology. 107: 391-8. PMID 6265479 DOI: 10.1002/Jcp.1041070311  0.341
1981 Kuzumaki N, More IA, Cochran AJ, Klein G. Thirteen new mammary tumor cell lines from different mouse strains. European Journal of Cancer. 16: 1181-92. PMID 6262088 DOI: 10.1016/0014-2964(80)90177-2  0.323
1981 Lau RY, Nonoyama M, Klein G. Somatic cell hybrids between human lymphoma and human myeloid leukemia cells. I. Induction of resident viral genome transcription and viral antigen formation by IUDR and TPA. Virology. 110: 259-69. PMID 6261446 DOI: 10.1016/0042-6822(81)90058-1  0.351
1981 Szigeti R, Volsky DJ, Luka J, Klein G. Membranes of EBV-carrying virus nonproducer cells inhibit leukocyte migration of EBV-seropositive but not seronegative donors. Journal of Immunology (Baltimore, Md. : 1950). 126: 1676-9. PMID 6260854  0.588
1981 Szigeti R, Luka J, Klein G. Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor. Cellular Immunology. 58: 269-76. PMID 6260386 DOI: 10.1016/0008-8749(81)90220-3  0.335
1981 Panet A, Falk H, Fenyö EM, Klein G. Restriction of murine leukemia proviral gene expression in somatic mouse cell hybrids. Virology. 106: 197-206. PMID 6254247 DOI: 10.1016/0042-6822(80)90244-5  0.33
1981 Szigeti R, Masucci MG, Masucci G, Klein E, Klein G. Interferon suppresses antigen- and mitogen-induced leukocyte migration inhibition. Nature. 288: 594-6. PMID 6160404 DOI: 10.1038/288594A0  0.375
1981 Koeffler H, Sparkes R, Billing R, Klein G. Somatic cell hybrid analyses of hematopoietic differentiation Blood. 58: 1159-1163. DOI: 10.1182/blood.v58.6.1159.1159  0.33
1980 Asjö B, Fenyö EM, Spira J, Klein G. Appearance and distribution of virally determined antigens in lymphoid organs of mice during leukemogenesis by Moloney leukemia virus. Leukemia Research. 4: 89-103. PMID 7412358 DOI: 10.1016/0145-2126(80)90049-1  0.342
1980 Najfeld V, Fialkow PJ, Karande A, Nilsson K, Klein G, Penfold G. Chromosome analyses of lymphoid cell lines derived from patients with chronic lymphocytic leukemia International Journal of Cancer. 26: 543-549. PMID 7239716 DOI: 10.1002/Ijc.2910260504  0.414
1980 Karande A, Fialkow PJ, Nilsson K, Povey S, Klein G, Najfeld V, Penfold G. Establishment of a lymphoid cell line from leukemic cells of a patient with chronic lymphocytic leukemia International Journal of Cancer. 26: 551-556. PMID 6263808 DOI: 10.1002/Ijc.2910260505  0.454
1980 Volsky DJ, Shapiro IM, Klein G. Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression. Proceedings of the National Academy of Sciences of the United States of America. 77: 5453-7. PMID 6254082 DOI: 10.1073/Pnas.77.9.5453  0.593
1980 Moar MH, Klein G. Effect of mitomycin C and hydroxyurea on the expression of the Epstein-Barr virus cycle following P3HR-1 superinfection. Intervirology. 13: 178-85. PMID 6246034 DOI: 10.1159/000149123  0.307
1980 Fenyö EM, Klein G, Povey S, Jeremiah SJ, Spira J, Wiener F, Harris H. Suppression and reappearance of N-tropic L virus production in somatic cell hybrids after introduction and loss of chromosomes carrying Fv-1b. European Journal of Cancer. 16: 357-68. PMID 6245889 DOI: 10.1016/0014-2964(80)90353-9  0.314
1980 Ragona G, Ernberg I, Klein G. Induction and biological characterization of the Epstein-Barr virus (EBV) carried by the Jijoye lymphoma line. Virology. 101: 553-7. PMID 6244705 DOI: 10.1016/0042-6822(80)90473-0  0.349
1980 Blazar B, Patarroyo M, Klein E, Klein G. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate. The Journal of Experimental Medicine. 151: 614-27. PMID 6244358 DOI: 10.1084/Jem.151.3.614  0.459
1980 Klein G, Vilcek J. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids. The Journal of General Virology. 46: 111-7. PMID 6243338 DOI: 10.1099/0022-1317-46-1-111  0.359
1980 Spira J, Wiener F, Ohno S, Klein G. Is trisomy cause or consequence of murine T cell leukemia development? Studies on Robertsonian translocation mice. Proceedings of the National Academy of Sciences of the United States of America. 76: 6619-21. PMID 316545 DOI: 10.1073/Pnas.76.12.6619  0.377
1980 Kuzumaki N, Ber R, More IA, Cochran AJ, Weiner F, Klein G. Viral expression and immunogenicity of CBA mammary carcinomas and their hybrid lines with an L-cell derivative (A9HT). European Journal of Cancer. 15: 1253-61. PMID 230057 DOI: 10.1016/0014-2964(79)90251-2  0.34
1980 Gunvén P, Klein G, Henle W, Henle G, Pearson GR. Epstein-barr virus (EBV)-associated antibodies in a case of Burkitt's lymphoma during 14 years of sustained remission Cancer Immunology Immunotherapy. 9: 193-197. DOI: 10.1007/Bf00205625  0.419
1979 Klein G, Klein E. Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids. European Journal of Cancer. 15: 551-7. PMID 436915 DOI: 10.1016/0014-2964(79)90092-6  0.361
1979 Moar MH, Rosén A, Klein G. Detection of virus and cellular-determined antigens in sity using [125I]protein A and autoradiography Journal of Immunological Methods. 30: 219-229. PMID 227963 DOI: 10.1016/0022-1759(79)90096-6  0.435
1979 Luka J, Kallin B, Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology. 94: 228-31. PMID 220786 DOI: 10.1016/0042-6822(79)90455-0  0.367
1979 van Beek WP, Nilsson K, Klein G, Emmelot P. Cell surface glycoprotein changes in Epstein-Barr virus-positive and -negative human hematopoietic cell lines. International Journal of Cancer. Journal International Du Cancer. 23: 464-73. PMID 220199 DOI: 10.1002/Ijc.2910230405  0.383
1979 Steinitz M, Klein G. Superinfection of EBV-carrying lines with herpes virus papio (HVP): induction of early antigen (EA) and inhibition of cellular DNA synthesis. European Journal of Cancer. 15: 217-22. PMID 220052 DOI: 10.1016/0014-2964(79)90063-X  0.378
1979 Mitelman F, Klein G, Andersson-Anvret M, Forsby N, Johansson B. 14q+ marker chromosome in an EBV-genome-negative lymph node without signs of malignancy in a patient with EBV-genome-positive nasopharyngeal carcinoma. International Journal of Cancer. 23: 32-6. PMID 215561 DOI: 10.1002/Ijc.2910230107  0.322
1979 Viallat J, Svedmyr E, Yefenof E, Klein G, Weiland O. Stimulation of human peripheral blood lymphocytes by autologous EBV-infected B cells. Cellular Immunology. 41: 1-8. PMID 214248 DOI: 10.1016/S0008-8749(78)80023-9  0.304
1979 Steplewski Z, Koprowski H, Andersson-Anvret M, Klein G. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells. Journal of Cellular Physiology. 97: 1-8. PMID 213442 DOI: 10.1002/Jcp.1040970102  0.355
1979 Mitelman F, Andersson-Anvret M, Brandt L, Catovsky D, Klein G, Manolov G, Manolova Y, Mark-Vendel E, Nilsson PG. Reciprocal 8;14 translocation in EBV-negative B-cell acute lymphocytic leukemia with Burkitt-type cells. International Journal of Cancer. 24: 27-33. PMID 90020 DOI: 10.1002/Ijc.2910240106  0.391
1979 Kuzumaki N, Klein G. Serologically defined, unique surface antigen on a mouse mammary adenocarcinoma. Journal of the National Cancer Institute. 62: 619-22. PMID 84092 DOI: 10.1093/Jnci/62.3.619  0.337
1979 Moar MH, Ber R, Klein G, Westman A, Eriksson I. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. International Journal of Cancer. 22: 669-74. PMID 82545 DOI: 10.1002/Ijc.2910220605  0.489
1979 Berkel I, Henle W, Henle G, Klein G, Ersoy F. Epstein Barr Virus (EBV) Associated Antibody (Ab) Patterns in Ataxia-Telangiectasia (A-T) Pediatric Research. 13: 76-76. DOI: 10.1203/00006450-197901000-00042  0.328
1979 Kallin B, Luka J, Klein G. Immunochemical Characterization of Epstein-Barr Virus-Associated Early and Late Antigens in n-Butyrate-Treated P3HR-1 Cells Journal of Virology. 32: 710-716. DOI: 10.1128/jvi.32.3.710-716.1979  0.302
1978 Fenyo EM, Yefenof E, Klein E, Klein G. Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus-induced cell surface antigens. The Journal of Experimental Medicine. 146: 1521-33. PMID 925612 DOI: 10.1084/Jem.146.6.1521  0.446
1978 Ber R, Fenyö EM, Klein G. Cell surface antigen expression in cytoplasts and karyoplasts of mouse L cells. Cancer Letters. 5: 69-73. PMID 688187 DOI: 10.1016/S0304-3835(78)80047-0  0.359
1978 Steinitz M, Bakács T, Klein G. Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes. International Journal of Cancer. 22: 251-7. PMID 212371 DOI: 10.1002/Ijc.2910220306  0.303
1978 McConnell I, Klein G, Lint TF, Lachmann PJ. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. European Journal of Immunology. 8: 453-8. PMID 211040 DOI: 10.1002/eji.1830080702  0.365
1978 Steinitz M, Koskimies S, Klein G, Mäkelä O. Establishment of specific antibody producing human lines by antigen preselection and EBV-transformation. Current Topics in Microbiology and Immunology. 81: 156-63. PMID 211003 DOI: 10.1007/978-3-642-67448-8_25  0.407
1978 Klein G, Falk L, Falk K. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to epstein-barr virus Intervirology. 10: 153-164. PMID 210135 DOI: 10.1159/000148980  0.386
1978 Ber R, Klein G, Moar M, Povey S, Rosén A, Westman A, Yefenof E, Zeuthen J. Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid. International Journal of Cancer. 21: 707-19. PMID 208988 DOI: 10.1002/Ijc.2910210607  0.437
1978 Kiessling R, Haller O, Fenyö EM, Steinitz M, Klein G. Mouse natural killer (NK) cell activity against human cell lines is not influenced by superinfection of the target cell with xenotropic murine C-type virus. International Journal of Cancer. 21: 460-5. PMID 208982 DOI: 10.1002/Ijc.2910210410  0.327
1978 Viallat J, Svedmyr E, Steinitz M, Klein G. Stimulation of peripheral human lymphocytes by autologous EBV genome-carrying lymphoblastoid cell lines. Cellular Immunology. 38: 68-75. PMID 208783 DOI: 10.1016/0008-8749(78)90032-1  0.31
1978 Yefenof E, Lundin L, Klein G. Shedding of anti-IgM from antibody-coated human lymphoma lines: differences between Epstein-Barr virus-negative lines and their virus-converted sublines. European Journal of Immunology. 8: 190-3. PMID 207534 DOI: 10.1002/Eji.1830080310  0.456
1978 Koliais S, Bjursell G, Adams A, Lindahl T, Klein G. State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line. Journal of the National Cancer Institute. 60: 991-4. PMID 205666 DOI: 10.1093/Jnci/60.5.991  0.336
1978 Moar MH, Siegert W, Klein G. Autoradiographic detection of Epstein-Barr virus (EBV)-associated early antigen in a variety of EBV DNA-containing lymphoblastoid cell lines previously designated as nonproducers. Intervirology. 9: 333-43. PMID 204604 DOI: 10.1159/000148955  0.39
1978 Moar MH, Siegert W, Klein G. Autoradiographic detection of the Epstein-Barr virus (EBV)-associated early antigen (EA) in lymphoblastoid cell lines. Haematology and Blood Transfusion. 20: 283-7. PMID 204549 DOI: 10.1007/978-3-642-66639-1_35  0.387
1978 Goldblum N, Ben-Bassat H, Mitrani S, Andersson-Anvret M, Goldblum T, Aghai E, Ramot B, Klein G. A case of an Epstein--Barr virus (EBV) genome-carrying lymphoma in an Israeli Arab child. European Journal of Cancer. 13: 693-8. PMID 202470 DOI: 10.1016/0014-2964(77)90055-X  0.326
1978 Einhorn L, Steinitz M, Yefenof E, Ernberg I, Bakacs T, Klein G. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. Cellular Immunology. 35: 43-58. PMID 202404 DOI: 10.1016/0008-8749(78)90125-9  0.331
1978 Vestergaard BF, Hesse J, Norrild B, Klein G. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV). International Journal of Cancer. 21: 323-8. PMID 75856 DOI: 10.1002/Ijc.2910210312  0.478
1978 Dölken G, Klein G. Radioimmunoassay for Epstein--Barr virus (EBV)-associated nuclear antigen (EBNA). Binding of iodinated antibodies to antigen immobilized in polyacrylamide gel. European Journal of Cancer. 13: 1277-86. PMID 73461 DOI: 10.1016/0014-2964(77)90036-6  0.363
1977 Clements GB, Klein G, Zeuthen J, Povey S. The selection of somatic cell hybrids between human lymphoma cell lines. Somatic Cell Genetics. 2: 309-24. PMID 1027146 DOI: 10.1007/Bf01538836  0.419
1977 Wiener F, Klein G, Harris H. Tumorgenicity of L cell derivatives and hybrid cells derived from them. Cancer Letters. 1: 207-10. PMID 1016946 DOI: 10.1016/S0304-3835(75)96836-6  0.401
1977 Asjö B, Kiessling R, Klein G, Povey S. Genetic variation in antibody response and natural killer cell activity against a Moloney virus-induced lymphoma (YAC). European Journal of Immunology. 7: 554-8. PMID 902682 DOI: 10.1002/Eji.1830070812  0.385
1977 Dalianis T, Anderson B, Klein G. Separation of cells with different histocompatibility (H-2) antigens by passage through cellular immunoadsorbent columns. European Journal of Immunology. 7: 154-8. PMID 324775 DOI: 10.1002/Eji.1830070308  0.372
1977 Klein G, Clements G, Zeuthen J, Westman A. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids. Cancer Letters. 3: 91-8. PMID 196751 DOI: 10.1016/S0304-3835(77)94516-5  0.381
1977 Olweny CL, Atine I, Kaddu-Mukasa A, Owor R, Andersson-Anvret M, Klein G, Henle W, de-Thé G. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda. Journal of the National Cancer Institute. 58: 1191-6. PMID 192894 DOI: 10.1093/Jnci/58.5.1191  0.314
1977 Ernberg I, Andersson-Anvret M, Klein G, Lundin L, Killanger D. Relationship between amount of Epstein-Barr virus-determined nuclear antigen per cell and number of EBV-DNA copies per cell. Nature. 266: 269-71. PMID 191759 DOI: 10.1038/266269A0  0.508
1977 Dalianis T, Klein G, Andersson B. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line,. International Journal of Cancer. 19: 460-7. PMID 191413 DOI: 10.1002/Ijc.2910190405  0.381
1977 de-Thé G, Vuillaume M, Giovanella BC, Klein G. Epithelial characteristics of tumor cells in nasophasyngeal carcinoma. Journal of the National Cancer Institute. 57: 1101-5. PMID 187791 DOI: 10.1093/Jnci/57.5.1101  0.326
1977 Troy FA, Fenyö EM, Klein G. Moloney leukemia virus-induced cell surface antigen: detection and characterization in sodium dodecyl sulfate gels. Proceedings of the National Academy of Sciences of the United States of America. 74: 5270-4. PMID 74831 DOI: 10.1073/Pnas.74.12.5270  0.302
1977 Trowbridge IS, Hyman R, Klein G. Human B cell line deficient in the expression of B cell-specific glycoproteins (GP 27,35) European Journal of Immunology. 7: 640-645. PMID 72671 DOI: 10.1002/Eji.1830070912  0.467
1977 Klein G, Zeuthen J, Terasaki P, Billing R, Honig R, Jondal M, Westman A, Clements G. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. International Journal of Cancer. 18: 639-52. PMID 62724 DOI: 10.1002/Ijc.2910180513  0.353
1976 Seiner M, Klein E, Klein G. Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases. Clinical Immunology and Immunopathology. 4: 374-81. PMID 1104228 DOI: 10.1016/0090-1229(75)90006-9  0.325
1976 Wiener F, Fenyö EM, Klein G, Davies AJ. Tumor-host cell hybrids in radiochimeras reconstituted with bone marrow and thymus grafts. Somatic Cell Genetics. 2: 81-92. PMID 1088456 DOI: 10.1007/Bf01542623  0.385
1976 Clements GB, Fenyö EM, Klein G. In vitro derived mouse A9 cell clones differing in malignancy: analysis by somatic cell hybridization with YACIR lymphoma cell clones. Proceedings of the National Academy of Sciences of the United States of America. 73: 2004-7. PMID 1064870 DOI: 10.1073/Pnas.73.6.2004  0.383
1976 Zech L, Haglund U, Nilsson K, Klein G. Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt and non Burkitt lymphomas International Journal of Cancer. 17: 47-56. PMID 946170 DOI: 10.1002/Ijc.2910170108  0.406
1976 Yefenof E, Klein G. Difference in antibody induced redistribution of membrane IgM in EBV geonome free and EBV positive human lymphoid cells. Experimental Cell Research. 99: 175-8. PMID 177301 DOI: 10.1016/0014-4827(76)90693-5  0.414
1976 Dölken G, Klein G. Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains. Virology. 70: 210-3. PMID 176804 DOI: 10.1016/0042-6822(76)90255-5  0.365
1976 Andersson M, Klein G, Zeigler JL, Henle W. Association of Epstein-Barr viral genomes with American Burkitt lymphoma. Nature. 260: 357-9. PMID 176599 DOI: 10.1038/260357A0  0.384
1976 Witz IP, Lee N, Klein G. Serologically detectable specific and cross-reactive antigens on the membrane of a polyoma virus-induced murine tumor. International Journal of Cancer. 18: 243-9. PMID 60289 DOI: 10.1002/Ijc.2910180215  0.342
1976 Jondal M, Klein G, Oldstone MB, Bokish V, Yefenof E. Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scandinavian Journal of Immunology. 5: 401-10. PMID 59946 DOI: 10.1111/j.1365-3083.1976.tb00294.x  0.318
1976 Klein G, Clements G, Zeuthen J, Westman A. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle. International Journal of Cancer. 17: 715-24. PMID 59708 DOI: 10.1002/Ijc.2910170605  0.361
1976 Ran M, Klein G, Witz IP. Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumor antibodies. International Journal of Cancer. 17: 90-97. PMID 55397 DOI: 10.1002/Ijc.2910170113  0.383
1975 Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proceedings of the National Academy of Sciences of the United States of America. 71: 4737-41. PMID 4373728 DOI: 10.1073/Pnas.71.12.4737  0.327
1975 Hilgers F, Rosén A, Lamon E, Klein G. Detection of Epstein-Barr virus-determined intracellular antigens in unfixed cells with labeled antibodies. Journal of the National Cancer Institute. 53: 949-55. PMID 4372371 DOI: 10.1093/Jnci/53.4.949  0.302
1975 Yefenof E, Klein G. Antibody-induced redistribution of normal and tumor associated surface antigens. Experimental Cell Research. 88: 217-24. PMID 4372068 DOI: 10.1016/0014-4827(74)90234-1  0.464
1975 Béchet JM, Fialkow PJ, Nilsson K, Klein G, Singh S. Immunoglobulin synthesis and glucose-6-phosphate dehydrogenase as cell markers in human lymphoblastoid cell lines. Experimental Cell Research. 89: 275-82. PMID 4218170 DOI: 10.1016/0014-4827(74)90791-5  0.338
1975 Bataillon G, Pross H, Klein G. Comparative in vitro sensitivity of twom methylcholanthrene-induced murine sarcoma lines to humoral and cellular immune cytotoxicity. International Journal of Cancer. 16: 255-65. PMID 1150353 DOI: 10.1002/Ijc.2910160208  0.318
1975 Dalens M, Zech L, Klein G. Origin of lymphoid lines established from mixed cultures of cord blood lymphocytes and explants from infectious mononucleosis, Burkitt lymphoma and healthy donors International Journal of Cancer. 16: 1008-1014. PMID 172457 DOI: 10.1002/Ijc.2910160614  0.385
1975 Desgranges C, Wolf H, De-Thé G, Shanmugaratnam K, Cammoun N, Ellouz R, Klein G, Lennert K, Muñoz N, Zur Hausen H. Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. International Journal of Cancer. 16: 7-15. PMID 170215 DOI: 10.1002/Ijc.2910160103  0.389
1975 Clements GB, Klein G, Povey S. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. International Journal of Cancer. 16: 125-33. PMID 170210 DOI: 10.1002/Ijc.2910160114  0.489
1975 Brown TD, Ernberg I, Klein G. Studies of Epstein-Barr virus (ebv)-associated nuclear antigen. I. assay in human lymphoblastoid cell lines by direct and indirect determination of 125I-IgG binding. International Journal of Cancer. 15: 606-16. PMID 166942 DOI: 10.1002/Ijc.2910150410  0.477
1975 Reedman BM, Hilgers J, Hilgers F, Klein G. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens. International Journal of Cancer. 15: 566-71. PMID 166941 DOI: 10.1002/Ijc.2910150406  0.481
1975 Menezes J, Leibold W, Klein G. Biological differences between epstein-barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction Experimental Cell Research. 92: 478-484. PMID 165958 DOI: 10.1016/0014-4827(75)90404-8  0.447
1975 Leibold W, Flanagan TD, Menezes J, Klein G. Induction of Epstein Barr virus associated nuclear antigen during in vitro transformation of human lymphoid cells Journal of the National Cancer Institute. 54: 65-68. PMID 163326 DOI: 10.1093/Jnci/54.1.65  0.422
1974 Wiener F, Dalianis T, Klein G, Harris H. Cytogenetic studies on the mechanism of formation of isoantigenic variants in somatic cell hybrids. I. Banding analyses of isoantigenic variant sublines derived from the fusion of TA3Ha carcinoma with MSWBS sarcoma cells. Journal of the National Cancer Institute. 52: 1779-96. PMID 4834408 DOI: 10.1093/Jnci/52.6.1779  0.372
1974 Klein G, Sugden B, Leibold W, Menezes J. Infection of EBV-genome-negative and-positive human lymphoblastoid: Cell lines with biologically different preparations of EBV Intervirology. 3: 232-244. PMID 4376804 DOI: 10.1159/000149760  0.396
1974 Klein G, Wiener F, Zech L, zur Hausen H, Reedman B. Segregation of the EBV determined nuclear antigen (EBNA) in somatic cell hybrids derived from the fusion of a mouse fibroblast and a human Burkitt lymphoma line International Journal of Cancer. 14: 54-64. PMID 4376508 DOI: 10.1002/Ijc.2910140108  0.35
1974 Brown TD, Ernberg I, Lamon EW, Klein G. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an 125-I-IgG-binding assay. International Journal of Cancer. 13: 785-94. PMID 4368574 DOI: 10.1002/Ijc.2910130607  0.454
1974 Ernberg I, Klein G, Kourilsky FM, Silvestre D. Differentiation Between Early and Late Membrane Antigen on Human Lymphoblastoid Cell Lines Infected With Epstein-Barr Virus. I. Immunofluorescence Journal of the National Cancer Institute. 53: 61-65. PMID 4365906 DOI: 10.1093/Jnci/53.1.61  0.443
1974 Povlsen CO, Fialkow PJ, Klein E, Klein G, Rygaard J, Wiener F. Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice. International Journal of Cancer. 11: 30-9. PMID 4364324 DOI: 10.1002/Ijc.2910110105  0.412
1974 Lamon EW, Ernberg I, Klein G. Detection of antigens determined by the Epstein Barr virus (EBV) in human lymphoblastoid cell culture lines by elution of specific radioiodine labeled antibody. Clinical Immunology and Immunopathology. 2: 216-33. PMID 4361279 DOI: 10.1016/0090-1229(74)90040-3  0.339
1974 Nyormoi O, Sinclair JH, Klein G. Isolation and characterization of an adherent, 8-azaguanine resistant variant of the Burkitt lymphoma cell line, Raji. Experimental Cell Research. 82: 241-51. PMID 4358110 DOI: 10.1016/0014-4827(73)90337-6  0.438
1974 Jondal M, Klein G. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. The Journal of Experimental Medicine. 138: 1365-78. PMID 4357682 DOI: 10.1084/Jem.138.6.1365  0.349
1974 Lindahl T, Klein G, Reedman BM, Johansson B, Singh S. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. International Journal of Cancer. 13: 764-72. PMID 4137165 DOI: 10.1002/Ijc.2910130605  0.304
1974 Reedman BM, Klein G, Pope JH, Walters MK, Hilgers J, Singh S, Johansson B. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. International Journal of Cancer. 13: 755-63. PMID 4136722 DOI: 10.1002/Ijc.2910130604  0.446
1974 Silvestre D, Ernberg I, Neauport-Sautes C, Kourilsky FM, Klein G. Differentiation Between Early and Late Membrane Antigen on Human Lymphoblastoid Cell Lines Infected With Epstein-Barr Virus. II. Immunoelectron Microscopy Journal of the National Cancer Institute. 53: 67-74. PMID 4134855 DOI: 10.1093/Jnci/53.1.67  0.426
1974 Reedman BM, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer. 11: 499-520. PMID 4133943 DOI: 10.1002/Ijc.2910110302  0.399
1974 Madalinski K, Slusarczyk J, Klein G. Letter: Hepatitis-B antigen and homologous antibodies in Burkitt's lymphoma and nasopharyngeal carcinoma. Lancet (London, England). 1: 869. PMID 4132822 DOI: 10.1016/S0140-6736(74)90520-0  0.336
1974 Klein G. Studies on the Epstein Barr virus genome and the EBV determined nuclear antigen in human malignant disease Symposia On Quantitative Biology. 39: 783-790. PMID 169032 DOI: 10.1101/SQB.1974.039.01.090  0.329
1973 Gunvén P, Klein G, Onyango J, Henle G, Henle W, Clifford P, Singh S, Demissie A, Svedmyr A. Antibodies associated with Epstein-Barr virus in Burkitt's lymphoma during injections of BCG or irradiated autochthonous tumor cells. Journal of the National Cancer Institute. 51: 45-56. PMID 4352753 DOI: 10.1093/Jnci/51.1.45  0.314
1973 Adams A, Klein G. Superinfection with Epstein-Barr virus of human lymphoid cell lines of different origin. Nature: New Biology. 242: 234-6. PMID 4349776 DOI: 10.1038/Newbio242234A0  0.469
1973 Fenyö EM, Grundner G, Wiener F, Klein E, Klein G, Harris H. The influence of the partner cell on the production of L virus and the expression of viral surface antigen in hybrid cells. The Journal of Experimental Medicine. 137: 1240-55. PMID 4349752 DOI: 10.1084/Jem.137.5.1240  0.367
1972 Strouk V, Grundner G, Fenyö EM, Lamon E, Skurzak H, Klein G. Lack of distinctive surface antigen on cells transformed by murine sarcoma virus. The Journal of Experimental Medicine. 136: 344-52. PMID 5043415 DOI: 10.1084/Jem.136.2.344  0.347
1972 Klein G, Friberg S, Harris H. Two kinds of antigen suppression in tumor cells revealed by cell fusion. The Journal of Experimental Medicine. 135: 839-49. PMID 5018053 DOI: 10.1084/jem.135.4.839  0.325
1972 Wiener F, Fenyö EM, Klein G, Harris H. Fusion of tumour cells with host cells. Nature: New Biology. 238: 155-9. PMID 4506195 DOI: 10.1038/Newbio238155A0  0.373
1972 Klein G, Harris H. Expression of polyoma-induced transplantation antigen in hybrid cell lines. Nature: New Biology. 237: 163-4. PMID 4338519 DOI: 10.1038/Newbio237163A0  0.309
1972 Einhorn N, Henle G, Henle W, Klein G, Clifford P. Effect of local radiotherapy on the antibody levels against EBV-induced early and capsid antigens (EA and VCA) in patients with certain malignant tumours. International Journal of Cancer. Journal International Du Cancer. 9: 182-92. PMID 4335641 DOI: 10.1002/Ijc.2910090121  0.334
1972 Klein E, Klein G. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells Cellular Immunology. 5: 201-208. DOI: 10.1016/0008-8749(72)90096-2  0.301
1971 Gergely L, Klein G, Ernberg I. Host cell macromolecular synthesis in cells containing EBV-induced early antigens, studied by combined immunofluorescence and radioautography. Virology. 45: 22-9. PMID 4329587 DOI: 10.1016/0042-6822(71)90108-5  0.31
1971 Gergely L, Klein G, Ernberg I. Appearance of Epstein-Barr virus-associated antigens in infected Raji cells. Virology. 45: 10-21. PMID 4329584 DOI: 10.1016/0042-6822(71)90107-3  0.372
1971 Silvestre D, Kourilsky FM, Klein G, Yata Y, Neauport-Sautes C, Levy JP. Relationship between the EBV-associated membrane antigen on Burkitt lymphoma cells and the viral envelope, demonstrated by immunoferritin labelling. International Journal of Cancer. 8: 222-233. PMID 4109105 DOI: 10.1002/Ijc.2910080206  0.437
1971 Fenyö EM, Grundner G, Klein G, Klein E, Harris H. Surface antigens and release of virus in hybrid cells produced by the fusion of A9 fibroblasts with Moloney Lymphoma cells. Experimental Cell Research. 68: 323-331. PMID 4108040 DOI: 10.1016/0014-4827(71)90157-1  0.451
1971 Grundner G, Fenyö EM, Klein G, Klein E, Bregula U, Harris H. Surface antigen expression in malignant sublines derived from hybrid cells of low malignancy. Experimental Cell Research. 68: 315-322. PMID 4108039 DOI: 10.1016/0014-4827(71)90156-X  0.447
1971 Fialkow PJ, Klein G, Giblett ER, Gothoskar B, Clifford P. Foreign-cell contamination in Burkitt tumours. Lancet (London, England). 1: 883-6. PMID 4102027 DOI: 10.1016/S0140-6736(71)92443-3  0.351
1970 Pearson G, Dewey F, Klein G, Henle G, Henle W. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. Journal of the National Cancer Institute. 45: 989-95. PMID 18605425 DOI: 10.1093/Jnci/45.5.989  0.324
1970 Yata J, Klein G, Hewetson J, Gergely L. Effect of metabolic inhibitors on membrane immunofluorescence reactivity of established Burkitt lymphoma cell lines. International Journal of Cancer. 5: 394-403. PMID 4916222 DOI: 10.1002/Ijc.2910050314  0.399
1970 Klein G, Geering G, Old LJ, Henle G, Henle W, Clifford P. Comparison of the anti-EBV titer and the EBV-associated membrane reactive and precipitating antibody levels in the sera of Burkitt lymphoma and nasopharyngeal carcinoma patients and controls. International Journal of Cancer. Journal International Du Cancer. 5: 185-94. PMID 4915449 DOI: 10.1002/Ijc.2910050204  0.377
1969 Yata J, Klein G. Some factors affecting membrane immunofluorescence reactivity of burkitt lymphoma tissue culture cell lines International Journal of Cancer. 4: 767-775. PMID 4907973 DOI: 10.1002/Ijc.2910040604  0.307
1969 Pearson G, Klein G, Henle G, Henle W, Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence. The Journal of Experimental Medicine. 129: 707-18. PMID 4886045 DOI: 10.1084/Jem.129.4.707  0.406
1969 Klein G, Pearson G, Henle G, Henle W, Goldstein G, Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. The Journal of Experimental Medicine. 129: 697-705. PMID 4886044 DOI: 10.1084/Jem.129.4.697  0.411
1969 McCormick KJ, Stenback WA, Trentin JJ, Klein G, Nadkarni JS, Nadkarni JJ, Clifford P. Complement-Fixation Test for Detection of Herpes-like Viruses in Cell Cultures of Burkitt's Lymphoma Journal of Virology. 3: 525-527. DOI: 10.1128/Jvi.3.5.525-527.1969  0.319
1968 Klein G, Pearson G, Henle G, Henle W, Diehl V, Niederman JC. Relation between Epstein-- Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. II. Comparison of cells and sera from patients with Burkitt's lymphoma and infectious mononucleosis. The Journal of Experimental Medicine. 128: 1021-30. PMID 4878907 DOI: 10.1084/Jem.128.5.1021  0.456
1968 Klein G, Pearson G, Nadkarni JS, Nadkarni JJ, Klein E, Henle G, Henle W, Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. The Journal of Experimental Medicine. 128: 1011-20. PMID 4878906 DOI: 10.1084/Jem.128.5.1011  0.468
1967 Klein E, Clifford P, Klein G, Hamberger CA. Further studies on the membrane immunofluorescence reaction of Burkitt lymphoma cells. International Journal of Cancer. 2: 27-36. PMID 5340964 DOI: 10.1002/Ijc.2910020106  0.313
1967 Klein G, Clifford P, Klein E, Stjernswärd J. Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proceedings of the National Academy of Sciences of the United States of America. 55: 1628-35. PMID 5336290 DOI: 10.1073/Pnas.55.6.1628  0.437
1961 Sjögren HO, Hellström I, Klein G. Resistance of polyoma virus immunized mice to transplantation of established polyoma tumors Experimental Cell Research. 23: 204-208. DOI: 10.1016/0014-4827(61)90078-7  0.301
1950 Klein E, Kurnick NB, Klein G. The effect of storage on the nucleic acid content and virulence of mouse ascites tumor Experimental Cell Research. 1: 127-134. DOI: 10.1016/0014-4827(50)90053-X  0.316
Show low-probability matches.